Stáhnout

Coriolus versicolor Supplementation as Immunonutrition in HPV Patients with Cervical Lesions (LSIL)

Silva Couto, J., Pereira da Silva, D. Portuguese Institute of Oncology, Coimbra, Portugal.

Early Phase II RCT of Tramates (Coriolus) versicolor (1500 mg TID PO) in Women with Stage (I/II/III) ER/PR Negative Breast Cancer

The main outcome was to study the mean rate of change in Natural Killer Cell Activity in patients who have undergone conventional breast câncer protocol: chemotherapy followed by radiotherapy in which there is a subseqent decrease in Natural Killer Cell Activity. The study was funded by CTRF and was halted as naturopaths were unable to recruit patients for the study. The attachments outline the rational for the study along with timeline.

Clinical study

Early Phase II RCT of Tramates (Coriolus) versicolor (1500 mg TID PO) in Women with Stage (I/II/III) ER/PR Negative Breast Cancer

Timeline

Coriolus versicolor supplementation in HPV patients
Dr. Jose Silva Couto and Dr. Daniel Pereira da Silva of the Cervical Pathology Unit of the Portuguese Institute of Oncology in Coimbra, Portugal
March 7th, at the 20th European Congress of Obstetrics and Gynaecology
This poster presents the results of a year long study on Coriolus versicolor supplementation in HPV patients with low-grade squamous intraepthithelial lesions (LSIL).

Cancer Prevention with Supplementation of Diets with Botanicals
by Karmali, A. and Fernandes, T.H.
ESCVN/ ECVCN – 5 – 7th October 2006 - Nantes
This work was conducted with a mushroom (Coriolus versicolor) which is in the market for human and animal use. Mushroom polysaccharides, particularly ß-glucans, have antitumour and immunomodulating properties.

Coriolus
by Dr. Jean Monro, Breakspear Hospital, Hempel Hemstead-Tel:44-1442-261-333. (www.breakspearmedical.com)
Journal of Integrative Medicine 2004;8:101-108
In this article Dr. Jean Monro of Breakspear Hospital, has demonstrated in a group of 36 patients who have had defined chronic fatigue syndrome and autonomic dysfunction that Coriolus MRL has been an immuno-therapeutic agent. It has improved natural killer cells numbers by 35% in this group with a two months course of treatment.

Treatment of Cancer with Mushroom Products
by Dr. Jean Monro, Breakspear Hospital, Hempel Hempstead-Tel: 44-1442-261-333 .
Archives of Environmental Health, August 2003 (Vol. 58 (No.8 )). Reprinted with permission of the Helen Dwight Reid Educational Foundation. Published by Heldref Publications, 1319 18th Street, NW, Washington, DC 20036-1802. Copyright © (2004).
In this article Dr. Monro points discusses how 20% of all cancers are triggered by viral infections. Dr. Monro outlines that having provided 30 Chronic Fatigue Syndrome patients Coriolus-MRL supplementation over eight weeks, there were significant improvements in the overall immune systems of the majority of the patients and that Coriolus supplementation could be utilized as a preventative immunutrition for those patients with such viral conditions that could develop into more serious oncological conditions i.e. HPV infection or Epstein Barr infection. Dr. Monro also outlines that Coriolus supplementation not only increases Natural Killer cell activity by 35%, but may also play a role in facilitating intercellular communication, thereby allowing the immune system to operate more effectively.

The Effectiveness of Coriolus versicolor in the Treatment of Secondary Phenomena Associated with HIV
by Dr. Grazia Rotolo, Piazza San Theodoro, 27100, Pavia, Italy
Presented at the 10th International Congress of Mucosal Immunology in Amsterdam, June 28th - July 1st, 1999.
This curiosity outlines the impact of Coriolus versicolor supplementation on the White Blood Count (WBC) in three HIV positive patients at the following intervals of supplementation: Days 1-15 at 3.0 grams per day; Days 16-45 at 1.5 grams per day. Results: a 45% increase in WBC over 45 days.
To Contact Dr. Grazia Rotolo, please contact grotolo@venus.it

The Effectiveness of Coriolus versicolor Supplementation in the Treatment of Kaposi sarcoma in HIV+Patients
by John Tindall and Elizabeth Clegg, Gateway Clinic, Community Health, South London, NHS Trust 108, Landor Road, London SW9 9NT England
Presented at the 10th International Congress of Mucosal Immunology in Amsterdam, June 28th - July 1st, 1999.
This curiosity outlines the impact of Coriolus supplementation (6.0 grams per day to 9.0 grams per day) on the CD4 levels and viral load levels of three (3) Kaposi sarcoma patients. Results: For Kaposi sarcoma patients, Coriolus versicolor supplementation at 6.0 grams per day to 9.0 grams per day can significantly increase CD4 levels and provide a better quality of life.
To Contact Mr John Tindall please contact Yuan Clinic at:
Yuan Clinic
c/o Green Healer
7 Clapham High Street
London SW4 7TS
United Kingdom
Tel/Fax: +44-207-622-9079 .

The Clinical Use of Coriolus versicolor Supplementation in HIV+ patients and the Impact on CD4 Count and Viral Load
by Marijke Pfeiffer-Centrum Voor Integrale Geneeskunde, Amsterdam.
Presented at the III International Symposium on Mushroom Nutrition in Milan on Saturday, March 10th, 2001.
This case study outlines the changes in CD4 levels and viral loads of eight (8) HIV+ patients onCoriolus versicolor supplementation levels of 1.5 grams per day over a twelve (12) month period. Results: Coriolus versicolor supplementation as low as 1.5 grams per day can increase CD4 levels and decrease viral loads in HIV+ patients. For similar impact in post-HAART patients the supplementation levels must be at 3.0 grams per day.
To contact Ms. Marijke Pfeiffer
Centrum Voor Integrale Geneeskundes
Amsterdam, The Netherlands
Fax:31-20-624-9710
Email: cig@xs4all.nl